L. Dillner et al., ASSOCIATION OF SERUM ANTIBODIES AGAINST DEFINED EPITOPES OF HUMAN PAPILLOMAVIRUS L1, E2, AND E7 ANTIGENS AND OF HPV DNA WITH INCIDENT CERVICAL-CANCER, Cancer detection and prevention, 19(5), 1995, pp. 381-393
In order to provide a large-scale evaluation of the association with c
ervical cancer of antibodies against human papillomavirus (HPV) antige
ns, sera from 233 patients with primary, untreated cervical cancer and
from 157 healthy age- and sex-matched blood donors were analyzed for
IgG and IgA antibodies against HPV-derived peptide antigens and agains
t bovine papillomavirus. Several serological responses were strongly a
ssociated with cervical cancer, notably the IgG response against the H
PV 16 epitopes L1:13 (Relative risk [RR]: 5.3), E2:9 (RR: 2.9), and E7
:5 (RR: 4.3), and the IgA response against an HPV 18 E2-derived antige
n (245:18, RR: 3.1). HPV DNA in corresponding cervical tumors was anal
yzed by Southern blotting (SE) and polymerase chain reaction (PCR) in
47 patients. Sixty-six percent of the patients carried HPV DNA as dete
rmined by SE, 91% of patients analyzed by PCR. Neither the antibody re
sponses, nor the presence of HPV DNA were significantly associated wit
h the biological properties of the tumors.